You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM)

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM)

Authors

Citation

Tanaka Y, Fleischmann R, Schiff M, et al
THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM)
Annals of the Rheumatic Diseases 2016;75:262-263.

Publication history

  • First published July 15, 2016.
Online issue publication 
February 08, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions